Dr Sergi Alonso
Lecturer in Health Economics & research associate
I am an interdisciplinary health economist with expertise in estimating the burden of disease and evaluating complex health interventions aiming at improving access to prevention, diagnosis and treatment in low- and middle-income countries. I am a lecturer in Health Economics at the Global Business School for Health (UCL) and a research associate at the School of Biodiversity, One Health and Veterinary Medicine (University of Glasgow).
I joined the Lamberton lab in January 2021 as part of a multidisciplinary team working on mathematical modelling for schistosomiasis research. I have analysed the effect of schistosomiasis and related morbidity on health-related quality of life, economic and societal outcomes. I am currently studying behavioural factors contributing to disease transmission by: (i) measuring trust in the healthcare system in Cameroon as a way to improve treatment compliance, and (ii) analysing household cooperation to provide communal latrines in rural Uganda for disease prevention & elimination.
I obtained my PhD for my work undertaken at the Barcelona Institute for Global Health (ISGlobal) and at the Manhiça Health Research Centre (CISM) in Mozambique, where I was based to conduct fieldwork and research in collaboration with National Control Programmes and international stakeholders, such as PATH, USAID or GAVI, the Vaccine Alliance.
I am currently a member of the World Health Organization (WHO) STAG-NTD Working Group on Monitoring, Evaluation and Research (WG MER) for the 2024 – 2027 tenure.
Email: sergi.alonso@glasgow.ac.uk
Google Scholar: Sergi Alonso
Linkedin: Sergi Alonso
ORCID: 0000-0001-6664-3736
Publications
S Alonso, M Arinaitwe, A Atuhaire, AB Nanksai, JM Prada, E McIntosh, PHL Lamberton (2024) The short-term impact of Schistosoma mansoni infection on health-related quality of life: implications for current elimination policies. Proceedings of the Royal Society B: Biological Sciences 291 20240449
Janoušková E, Clark J, Kajero O, Alonso S, Lamberton PHL, Betson M, Prada JM. 2022. Public health policy pillars for the sustainable elimination of zoonotic schistosomiasis. Frontiers in Tropical Medicine 3:826501.
Alonso S, Zulliger R, et al. Cost and cost-effectiveness of indoor residual spraying with pirimiphos-methyl in a high malaria transmission district of Mozambique with high access to standard insecticide-treated nets. Malaria Journal 2021, 20:143. DOI: 10.1186/s12936-021-03687-1.
Alonso S, Kent S, Cobiac L, et al. Impact of the 2003-2018 population salt reduction programme in England: a modelling study. Hypertension. 2021, 77:1086–1094. DOI: 10.1161/HYPERTENSIONAHA.120.16649.
Cirera L, Galata B, Alonso S, et al. Moving towards malaria elimination in southern Mozambique: Cost and cost- effectiveness of mass drug administration combined with intensified malaria control. PLoS ONE 2020, 15: e0235631. DOI: 10.1371/journal.pone.0235631.
Alonso S, Chaccour C, et al. The economic burden of malaria on households and the health system in a high transmission district of Mozambique. Malaria Journal 2019, 18:360. DOI: 10.1186/s12936-019-2995-4.
Alonso S, Cambaco O, et al. Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in Southern Mozambique. BMC Public Health 2019 19:1031. DOI: 10.1186/s12889-019-7338-4.
Sicuri E, Bacoum F, Nonvignon J, Alonso S, et al. The costs of implementing vaccination with the RTS,S malaria vaccine in five sub-Saharan African countries. MDM Policy & Practice 2019, 4:2381468319896280. DOI: 10.1177/2381468319896280.
Chaccour C*, Alonso S*, Zulliger R*, et al. Combination of long-lasting insecticide-treated nets with indoor residual spraying for malaria control in Zambezia, Mozambique: a cluster-randomized trial study protocol. BMJ Global Health 2018, 3:e000610. DOI: 10.1136/bmjgh-2017-000610. *Equal contributors.
Sicuri E, Bardaji A, Sanz S, Alonso S, et al. Patients’ costs, socio-economic and health system aspects associated with malaria in pregnancy in an endemic area of Colombia. PLOS NTDs 2018, 12:e0006431. DOI: 10.1371/journal.pntd.0006431.
Alonso S, Munguambe K, Sicuri E. Market for Artemether-Lumefantrine to treat childhood malaria in a district of Southern Mozambique. Health Economics 2017, 26:345-360. DOI: 10.1002/hec.3514.
Alonso S, Tachfouti N, et al. Cost-effectiveness of diagnostic-therapeutic strategies for pediatric Visceral Leishmaniasis in Morocco. BMJ Global Health 2017, 2:e000315. DOI: 10.1136/ bmjgh-2017-000315.
Tachfouti N, Najdi A, Alonso S, et al. Cost of pediatric Visceral Leishmaniasis Care in Morocco. PLOS One 2016, 11:e0155482. DOI: 10.1371/journal. pone.0155482.
Pastor L, Casellas A, Carrillo J, Alonso S, et al. Plasma IP-10 Levels as a Powerful Tool to Detect Acute HIV Infection in Patients with Undifferentiated Fever. Scientific Reports 2017, 7:8104. DOI: 10.1038/s41598-017-08218-0.